ALNYLAM PHARMACEUTICALS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Garg Pushkal | CMO & EVP Dev & Med Affairs | Option Exercise | 23,876 | $88.95 | $2,123,770 | 39,581 | Jan 27, 2025 |
| SHARP PHILLIP A | — | Option Exercise | 11,250 | $131.21 | $1,476,113 | 11,250 | Jan 23, 2025 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | Sale | 100 | $252.94 | $25,294 | 15,846 | Dec 12, 2024 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sale | 26 | $247.77 | $6,442 | 15,855 | Nov 27, 2024 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | Award / Grant | 3,434 | — | — | 32,326 | Nov 26, 2024 |
| Tanguler Tolga | EVP, Chief Commercial Officer | Sale | 84 | $252.27 | $21,191 | 13,191 | Nov 26, 2024 |
| Greenstreet Yvonne | Chief Executive Officer | Sale | 300 | $252.27 | $75,681 | 78,880 | Nov 25, 2024 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | Sale | 97 | $252.27 | $24,470 | 17,457 | Nov 25, 2024 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | Award / Grant | 96 | — | — | 15,705 | Oct 8, 2024 |
| Hesslein Robert W. | EVP, CLO and Secretary | Award / Grant | 7,245 | — | — | 7,245 | Oct 1, 2024 |
| Reitan Colleen F | — | Award / Grant | 775 | — | — | 775 | Aug 29, 2024 |
| Greenstreet Yvonne | Chief Executive Officer | Sale | 15,000 | $280.00 | $4,200,000 | 73,441 | Aug 20, 2024 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sale | 1,158 | $273.73 | $316,979 | 13,016 | Aug 12, 2024 |
| Ausiello Dennis A | — | Option Exercise | 9,000 | $105.26 | $947,340 | 20,386 | Aug 6, 2024 |
| Greenstreet Yvonne | Chief Executive Officer | Option Exercise | 15,148 | $85.00 | $1,287,580 | 88,589 | Aug 1, 2024 |
| Greenstreet Yvonne | Chief Executive Officer | Sale | 7,093 | $261.00 | $1,851,273 | 73,441 | Jul 11, 2024 |
| SCHULMAN AMY W | — | Option Exercise | 8,500 | $131.21 | $1,115,285 | 16,936 | Jun 25, 2024 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | Sale | 45 | $226.82 | $10,207 | 17,548 | Jun 25, 2024 |
| Greenstreet Yvonne | Chief Executive Officer | Award / Grant | 16,953 | — | — | 88,835 | Jun 25, 2024 |
| Tanguler Tolga | EVP, Chief Commercial Officer | Sale | 18 | $225.55 | $4,060 | 13,175 | Jun 25, 2024 |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sale | 45 | $221.71 | $9,977 | 15,334 | Jun 25, 2024 |
| PYOTT DAVID E I | — | Option Exercise | 7,470 | $71.99 | $537,765 | 32,586 | Jun 24, 2024 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | Sale | 266 | $229.06 | $60,930 | 29,978 | Jun 24, 2024 |
| SCHULMAN AMY W | — | Sale | 10,121 | $148.21 | $1,500,033 | 20,015 | May 29, 2024 |
| Tanguler Tolga | EVP, Chief Commercial Officer | Award / Grant | 4,751 | — | — | 9,987 | Mar 1, 2024 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | Award / Grant | 4,751 | — | — | 13,417 | Mar 1, 2024 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | Award / Grant | 7,741 | — | — | 27,219 | Mar 1, 2024 |
| Greenstreet Yvonne | Chief Executive Officer | Award / Grant | 23,754 | — | — | 71,882 | Mar 1, 2024 |
| SHARP PHILLIP A | — | Sale | 101 | $154.07 | $15,561 | 516 | Feb 29, 2024 |
| Tanguler Tolga | EVP, Chief Commercial Officer | Sale | 14 | $157.30 | $2,202 | 5,237 | Feb 28, 2024 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | Sale | 247 | $154.54 | $38,171 | 19,805 | Feb 28, 2024 |
| Greenstreet Yvonne | Chief Executive Officer | Option Exercise | 5,921 | — | — | 51,060 | Feb 28, 2024 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | Sale | 1 | $158.09 | $158 | 8,666 | Feb 28, 2024 |
| Franchini Indrani Lall | EVP, CLO & Secretary | Sale | 66 | $156.38 | $10,321 | 4,143 | Feb 28, 2024 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | Sale | 120 | $149.03 | $17,884 | 18,144 | Feb 16, 2024 |
| Tanguler Tolga | EVP, Chief Commercial Officer | Sale | 121 | $149.03 | $18,033 | 4,070 | Feb 16, 2024 |
| Greenstreet Yvonne | Chief Executive Officer | Award / Grant | 16,953 | — | — | 52,169 | Feb 16, 2024 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | Sale | 480 | $147.50 | $70,800 | 8,160 | Feb 15, 2024 |
| Franchini Indrani Lall | EVP, CLO & Secretary | Sale | 269 | $172.38 | $46,370 | 3,584 | Feb 1, 2024 |
| BONNEY MICHAEL W | — | Option Exercise | 30,000 | $96.45 | $2,893,500 | 46,029 | Dec 27, 2023 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | Award / Grant | 4,518 | — | — | 8,863 | Aug 4, 2023 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | Award / Grant | 3,109 | — | — | 19,333 | Aug 4, 2023 |
| Greenstreet Yvonne | Chief Executive Officer | Sale | 192 | $189.31 | $36,348 | 35,216 | Aug 4, 2023 |
| Vaishnaw Akshay | President | Award / Grant | 3,859 | — | — | 26,831 | Aug 4, 2023 |
| BONNEY MICHAEL W | — | Option Exercise | 22,477 | — | — | 22,477 | Aug 3, 2023 |
| Greenstreet Yvonne | Chief Executive Officer | Award / Grant | 16,952 | — | — | 37,947 | Apr 27, 2023 |
| Poulton Jeffrey V. | EVP, Chief Financial Officer | Award / Grant | 3,277 | — | — | 12,683 | Apr 27, 2023 |
| Tanguler Tolga | EVP, Chief Commercial Officer | Sale | 122 | $193.18 | $23,568 | 3,155 | Apr 27, 2023 |
| Vaishnaw Akshay | President | Sale | 1,013 | $194.94 | $197,474 | 18,162 | Apr 27, 2023 |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | Sale | 779 | $194.94 | $151,858 | 7,009 | Apr 27, 2023 |